Additionally, DC vaccine/CIK cell hybrids (DC-CIKs) have been studied in combination with pembrolizumab and TKIs in advanced RCC with encouraging preliminary results [209,210]. Here, TRAF3IP2 is linked to renal cell carcinoma.